rs202241382

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2

The NM_024675.4(PALB2):​c.1000T>G​(p.Tyr334Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000239 in 1,613,172 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y334C) has been classified as Likely benign. The gene PALB2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.00024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 3 hom. )

Consequence

PALB2
NM_024675.4 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: -0.444

Publications

9 publications found
Variant links:
Genes affected
PALB2 (HGNC:26144): (partner and localizer of BRCA2) This gene encodes a protein that may function in tumor suppression. This protein binds to and colocalizes with the breast cancer 2 early onset protein (BRCA2) in nuclear foci and likely permits the stable intranuclear localization and accumulation of BRCA2. [provided by RefSeq, Jul 2008]
PALB2 Gene-Disease associations (from GenCC):
  • hereditary breast carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
  • PALB2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia complementation group N
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P
  • pancreatic cancer, susceptibility to, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 7 benign, 29 uncertain in NM_024675.4
BP4
Computational evidence support a benign effect (MetaRNN=0.0045898557).
BP6
Variant 16-23635546-A-C is Benign according to our data. Variant chr16-23635546-A-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 126580.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024675.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALB2
NM_024675.4
MANE Select
c.1000T>Gp.Tyr334Asp
missense
Exon 4 of 13NP_078951.2
PALB2
NM_001407296.1
c.940T>Gp.Tyr314Asp
missense
Exon 3 of 12NP_001394225.1
PALB2
NM_001407297.1
c.1000T>Gp.Tyr334Asp
missense
Exon 4 of 12NP_001394226.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALB2
ENST00000261584.9
TSL:1 MANE Select
c.1000T>Gp.Tyr334Asp
missense
Exon 4 of 13ENSP00000261584.4Q86YC2
PALB2
ENST00000568219.5
TSL:1
c.115T>Gp.Tyr39Asp
missense
Exon 4 of 13ENSP00000454703.2H3BN63
PALB2
ENST00000561514.3
TSL:5
c.1006T>Gp.Tyr336Asp
missense
Exon 4 of 13ENSP00000460666.3A0AA52I2C1

Frequencies

GnomAD3 genomes
AF:
0.000237
AC:
36
AN:
152210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00311
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000530
AC:
133
AN:
250838
AF XY:
0.000405
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00500
Gnomad NFE exome
AF:
0.000150
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.000239
AC:
349
AN:
1460962
Hom.:
3
Cov.:
32
AF XY:
0.000216
AC XY:
157
AN XY:
726812
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33346
American (AMR)
AF:
0.00
AC:
0
AN:
44556
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26120
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86198
European-Finnish (FIN)
AF:
0.00569
AC:
304
AN:
53382
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000252
AC:
28
AN:
1111568
Other (OTH)
AF:
0.000282
AC:
17
AN:
60340
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000237
AC:
36
AN:
152210
Hom.:
0
Cov.:
32
AF XY:
0.000255
AC XY:
19
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41458
American (AMR)
AF:
0.00
AC:
0
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00311
AC:
33
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68024
Other (OTH)
AF:
0.000478
AC:
1
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000798
Hom.:
0
Bravo
AF:
0.0000189
ExAC
AF:
0.000535
AC:
65

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Hereditary cancer-predisposing syndrome (4)
-
1
1
not provided (2)
-
-
1
Familial cancer of breast (1)
-
-
1
Fanconi anemia complementation group N (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.090
BayesDel_addAF
Benign
-0.45
T
BayesDel_noAF
Benign
-0.65
CADD
Benign
0.36
DANN
Benign
0.46
DEOGEN2
Benign
0.036
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.094
N
LIST_S2
Benign
0.54
T
M_CAP
Benign
0.0094
T
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.4
L
PhyloP100
-0.44
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-2.4
N
REVEL
Benign
0.013
Sift
Benign
0.22
T
Sift4G
Benign
0.26
T
Polyphen
0.096
B
Vest4
0.14
MVP
0.28
MPC
0.086
ClinPred
0.032
T
GERP RS
-2.1
Varity_R
0.067
gMVP
0.27
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202241382; hg19: chr16-23646867; COSMIC: COSV105847619; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.